The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Safety of high-dose nicotinamide: a review
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burkart, V., Wang, Z.-Q., Radons, J., Heller, B., Herceg, Z., Stingl, L., Wagner, E. F., & Kolb, H. (1999) · Nature Medicine · doi:10.1038/6535 · Cited by 372
Efficacy and safety of an extended-release niacin (Niaspan): a long-term study
Capuzzi, D. M., Guyton, J. R., Morgan, J. M., Goldberg, A. C., Kreisberg, R. A., Brusco, O. A., & Brody, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00731-0 · Cited by 254
Hepatic toxicity of unmodified and time-release preparations of niacin
Rader, J. I., Calvert, R. J., & Hathcock, J. N. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90018-7 · Cited by 135
Pancreatic Islet Cell Tumors Produced by the Combined Action of Streptozotocin and Nicotinamide
Rakieten, N., Gordon, B. S., Beaty, A., Cooney, D. A., Davis, R. D., & Schein, P. S. (1971) · Experimental Biology and Medicine · doi:10.3181/00379727-137-35561 · Cited by 132
A Population Based Strategy to Prevent Insulin-Dependent Diabetes Using Nicotinamide
Elliott, R. B., Pilcher, C. C., Fergusson, D. M., & Stewart, A. W. (1996) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1996.9.5.501 · Cited by 99
THE INHIBITION OF RAT GROWTH BY NICOTINAMIDE
Handler, P., & Dann, W. J. (1942) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)44953-8 · Cited by 88
Alderman, J. D., Pasternak, R. C., Sacks, F. M., Smith, H. S., Monrad, E. S., & Grossman, W. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90754-6 · Cited by 80
High dose nicotinamide in the treatment of necrobiosis lipoidica
HANDFIELD-JONES, S. E., Jones, S. K., & Peachey, R. D. G. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb02572.x · Cited by 78
Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)
Pozzilli, P., Visalli, N., Signore, A., Baroni, M. G., Buzzetti, R., Cavallo, M. G., Boccuni, M. L., Fava, D., Gragnoli, C., Andreani, D., et al. (1995) · Diabetologia · doi:10.1007/s001250050362 · Cited by 75
Nicotinamide's Effects on Glucose Metabolism in Subjects at Risk For IDDM
Greenbaum, C., Kahn, S., & Palmer, J. (1996) · Diabetes · doi:10.2337/diab.45.11.1631 · Cited by 65
Cited by
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
Atkinson, M. A., & Eisenbarth, G. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05415-0 · Cited by 1,491
Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205670200 · Cited by 1,002
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
“patic toxicity athighdoses ( 3g/d) (178).”
Bogan, K. L., & Brenner, C. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155443 · Cited by 707
A Phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention
Chen, A. C., Martin, A. J., Choy, B., Fernández-Peñas, P., Dalziell, R. A., McKenzie, C. A., Scolyer, R. A., Dhillon, H. M., Vardy, J. L., Kricker, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506197 · Cited by 648
Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15786-3 · Cited by 534
Self-citationCutaneous Squamous Cell Carcinoma
Waldman, A., & Schmults, C. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.08.001 · Cited by 424
Green, K. N., Steffan, J. S., Martinez-Coria, H., Sun, X., Schreiber, S. S., Thompson, L. M., & LaFerla, F. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3203-08.2008 · Cited by 404
“Nicotinamide prevents cognitive deficits in AD mouse model Nicotinamide, also known as niacinamide, is a sirtuin inhibitor and the biologically active form of niacin (vitamin B3) which has been widely used clinically for 40 years (Knip et al., 2000).”
BackgroundBiodegradable therapeutic MOFs for the delivery of bioactive molecules
Miller, S. R., Heurtaux, D., Baati, T., Horcajada, P., Grenèche, J.-M., & Serre, C. (2010) · Chemical Communications · doi:10.1039/c001181a · Cited by 306
NAD+ and Vitamin B3: From Metabolism to Therapies
Sauve, A. A. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120758 · Cited by 304
Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes
Wilson, R. D., & Islam, M. S. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70739-9 · Cited by 289
NAD + Metabolism in Cardiac Health, Aging, and Disease
Abdellatif, M., Sedej, S., & Kroemer, G. (2021) · Circulation · doi:10.1161/circulationaha.121.056589 · Cited by 255
Hui, F., Tang, J., Williams, P. A., McGuinness, M. B., Hadoux, X., Casson, R. J., Coote, M., Trounce, I. A., Martin, K. R., van Wijngaarden, P., et al. (2020) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.13818 · Cited by 226
Liu, D., Pitta, M., Jiang, H., Lee, J.-H., Zhang, G., Chen, X., Kawamoto, E. M., & Mattson, M. P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.020 · Cited by 238
Irie, J., Inagaki, E., Fujita, M., Nakaya, H., Mitsuishi, M., Yamaguchi, S., Yamashita, K., Shigaki, S., Ono, T., Yukioka, H., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0313 · Cited by 191
Turunc Bayrakdar, E., Uyanikgil, Y., Kanit, L., Koylu, E., & Yalcin, A. (2014) · Free Radical Research · doi:10.3109/10715762.2013.857018 · Cited by 169
Possible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment
Hwang, E., & Song, S. (2020) · Biomolecules · doi:10.3390/biom10050687 · Cited by 144
Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Harder, J. M., Guymer, C., Wood, J. P. M., Daskalaki, E., Chidlow, G., Zhang, C., Balasubramanian, R., Cardozo, B. H., Foxworth, N. E., Deering, K. E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014213117 · Cited by 127
“Pyruvate and NAM are ideal treatments for clinical use, with long histories and favorable safety profiles in humans (5, 33).”
Hathorn, T., Snyder-Keller, A., & Messer, A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.017 · Cited by 123
Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety
Snaidr, V. A., Damian, D. L., & Halliday, G. M. (2019) · Experimental Dermatology · doi:10.1111/exd.13819 · Cited by 121
Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
Williams, P. A., Harder, J. M., & John, S. W. M. (2017) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000767 · Cited by 102
Metadata
- Authors
- Knip, M., Douek, I. F., Moore, W. P. T., Gillmor, H. A., McLean, A. E. M., Bingley, P. J., & Gale, E. A. M.
- Venue
- Diabetologia
- Published
- 2000-10-26
- Volume
- 43
- Issue
- 11
- Pages
- 1337-1345
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1988154847
- Cited by
- 422
- References
- 26
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.